DRKS00016416招募中不适用
Prospective evaluation of detection of circulating tumor DNA (ctDNA) to predict recurrence after definitive therapy of localized stage lung cancer (PREDICT) - PREDICT
Klinik für Kardiologie und Pneumologie, Klinikum Esslingen0 个研究点目标入组 180 人开始时间: 2019年4月8日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- 入组人数
- 180
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 Years 至 one(—)
- 性别
- All
入选标准
- •Patients with NSCLC stage I-IVA with planned curative therapy. SCLC stage I-IIIC with planned curative therapy.
排除标准
- 未提供
研究者
相似试验
招募中
不适用
A prospective study of measurement of circulating tumor DNA during neoadjuvant chemotherapy for esophageal cancerresectable advanced esophageal cancerJPRN-UMIN000029788Wakayama medical university40
已完成
不适用
Evaluation of the efficacy of the detection of the significant cancer and the safety in MRI-TRUS fusion image-guided prostate biopsy: multi-institutional study in Japaprostate cancer suspectedJPRN-UMIN000042397Tokai University400
已完成
不适用
Evaluation of AI-assisted software for colonoscopycolorectal lesionJPRN-UMIN000040677Digestive Disease Center, Showa University Northern Yokohama Hospital2,261
招募中
2 期
Exploratory study to evaluate the detection ability of photodynamic endoscopic imaging for differentiated gastric cancer and gastric adenomaJPRN-jRCTs061230040Isomoto Hajime80
已完成
不适用
Prospective evaluation of the DEtection rate of clinically significant PROstate cancer by mpMRI and PSMA-PET/CT fusion biopsyC61Malignant neoplasm of prostateProstate cancerDRKS00024134Klinik und Poliklinik für Urologie und Kinderurologie Universitätsklinikum Bonn246
